Finance

Beta
Lists
Q1 2027 earnings • in 3 days
See details
CIPLA:NSE
Cipla Ltd
1 436,50 ₹
+1,25%
(+17,80) 1D
20 шіл., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CIPLA...
Open
1 425,70 ₹
High
1 466,60 ₹
Low
1 419,50 ₹
Mkt. cap
1,16 трлн
Avg. vol.
1,39 млн
Volume
1,49 млн
Dividend
0,90%
Quarterly dividend
3,25 ₹
Ex-dividend date
2026 ж. 05 мау.
P/E ratio
29,93
52-wk high
1 673,00 ₹
52-wk low
1 165,70 ₹
EPS
48,00 ₹
Shares outstanding
805,67 млн
No. of employees
31 мың
Open
1 425,70 ₹
High
1 466,60 ₹
Low
1 419,50 ₹
Mkt. cap
1,16 трлн
Avg. vol.
1,39 млн
Volume
1,49 млн
Dividend
0,90%
Quarterly dividend
3,25 ₹
Ex-dividend date
2026 ж. 05 мау.
P/E ratio
29,93
52-wk high
1 673,00 ₹
52-wk low
1 165,70 ₹
EPS
48,00 ₹
Shares outstanding
805,67 млн
No. of employees
31 мың
News stories
From sources across the web
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees31,4 мың
Founded1935
HeadquartersМумбаи, Махараштра, Үндістан
SectorPharmaceutical industry
Websitecipla.com
Next call 3 күннен кейін
23 шіл., бс, 12:30
Fiscal period
Q1 2027
EPS / Est. (INR)
- / 10,42 ₹
Revenue / Est. (INR)
- / 71,36 млрд
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
68,37 млрд
74,47 млрд
69,63 млрд
65,80 млрд
Cost of goods sold
21,71 млрд
24,98 млрд
26,32 млрд
25,10 млрд
Cost of revenue
21,71 млрд
24,98 млрд
26,32 млрд
25,10 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,12 млрд
13,15 млрд
13,25 млрд
28,23 млрд
Operating expense
31,41 млрд
33,52 млрд
33,54 млрд
33,30 млрд
Total operating expenses
53,12 млрд
58,50 млрд
59,86 млрд
58,39 млрд
Operating income
15,25 млрд
15,98 млрд
9,77 млрд
7,41 млрд
Other non operating income
2,59 млрд
2,69 млрд
2,06 млрд
-5,35 млрд
EBT including unusual items
17,69 млрд
18,54 млрд
8,93 млрд
6,99 млрд
EBT excluding unusual items
17,69 млрд
18,54 млрд
11,69 млрд
4,51 млрд
Income tax expense
4,78 млрд
5,00 млрд
2,19 млрд
1,57 млрд
Effective tax rate
27,01%
27,00%
24,48%
22,44%
Other operating expenses
15,76 млрд
17,40 млрд
17,51 млрд
2,51 млрд
Net income
12,98 млрд
13,51 млрд
6,76 млрд
5,55 млрд
Net profit margin
18,98%
18,14%
9,71%
8,43%
Earnings per share
16,06
16,72
10,94
6,86
Interest and investment income
-
-
-
2,07 млрд
Interest expense
-140,50 млн
-131,80 млн
-140,30 млн
-69,70 млн
Net interest expenses
-140,50 млн
-131,80 млн
-140,30 млн
2,00 млрд
Depreciation and amortization charges
2,53 млрд
2,97 млрд
2,78 млрд
2,56 млрд
EBITDA
17,49 млрд
18,73 млрд
12,00 млрд
9,82 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer